Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
174,282,170
-
Total 13F shares
-
41,738,575
-
Share change
-
+437,845
-
Total reported value
-
$512,085,638
-
Price per share
-
$12.30
-
Number of holders
-
73
-
Value change
-
+$3,227,239
-
Number of buys
-
44
-
Number of sells
-
11
Institutional Holders of Prime Medicine, Inc. - COMMON STOCK (PRME) as of Q1 2023
As of 31 Mar 2023,
Prime Medicine, Inc. - COMMON STOCK (PRME) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,738,575 shares.
The largest 10 holders included
Alphabet Inc., FMR LLC, Redmile Group, LLC, ARK Investment Management LLC, MWG Management Ltd., FIL Ltd, BlackRock Inc., BAKER BROS. ADVISORS LP, Nikko Asset Management Americas, Inc., and Sumitomo Mitsui Trust Holdings, Inc..
This page lists
73
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.